BIOD

Biodel Inc. Press Releases

$1.39
*  
0.03
2.21%
Get BIOD Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading BIOD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Biodel Reports Fourth Quarter Fiscal Year 2014 Financial Results
12/17/2014 4:00:00 PM - Market Wire
▲4.51 % Price Change since this news event. The Volume Ratio is 2.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biodel to Report Fourth Quarter Fiscal Year 2014 Financial Results on December 17, 2014
12/10/2014 4:00:00 PM - Market Wire
▼-1.42 % Price Change since this news event. The Volume Ratio is 0.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biodel Initiates Clinical Proof of Concept Study in Glucagon Emergency Management Program
12/4/2014 4:19:00 PM - Market Wire
▼-0.71 % Price Change since this news event. The Volume Ratio is 1.1.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Biodel Successfully Defends Ultra-Rapid-Acting Insulin Formulation Technology in European Patent Office Opposition Proceedings
11/18/2014 4:02:00 PM - Market Wire